MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2017 International Congress

    Validation of the performance based Erlangen Test of Activities of Daily Living in PD

    I. Liepelt-Scarfone, L. Liebig, P. Sulzer, D. Berg (Tübingen, Germany)

    Objective: The Erlangen Test of Activities of Daily Living (E-ADL) is a performance-based test to assess the activity of daily living (ADL) dysfunction associated with…
  • 2017 International Congress

    Subthalamic nucleus local field potential activity during the sleep-wake cycle

    A. Tekriwal, J. Thompson, A. Abosch (Aurora, CO, USA)

    Objective: Characterize changes in Subthalamic Nucleus local field potential (STN LFP) activity related to stages of the sleep-wake cycle. Background: Deep brain stimulation (DBS) devices…
  • 2017 International Congress

    Acute L-dopa Challenge Test In Early Parkinsonism With Respect To Presence Of Red Flag Signs &MRIAbnormalitis

    M. ACHARYA, A. BISWAS, A. Chatterjee, S. DAS (KOLKATA, India)

    Objective: In this study we have tried to find any association between acute levodopa challenge responsiveness,red flag signs of parkinsonism and neuroimaging abnormality  Background: Distinguishing…
  • 2017 International Congress

    Epidemiological profile of parkinsonism in a tertiary neurological clinic in the northeast of Brazil.

    R. Prado, P. Macêdo, A. Santiago, R. Sá, J. Santos, M. Machado (Aracaju, Brazil)

    Objective: To identify the epidemiological profile of patients with parkinsonism in a tertiary movement disorders clinic in the northeast of Brazil.To identify the epidemiological profile…
  • 2017 International Congress

    PD Check-In: Supporting people with Parkinson’s Disease in self-managed maintenance of communication following intensive speech treatment

    A. Finnimore, D. Theodoros, A. Rumbach (Brisbane, Australia)

    Objective: To investigate a supported self-management model of care, PD Check-In, for long term maintenance of speech, communication and quality of life in Parkinson’s Disease…
  • 2017 International Congress

    Factors that contribute to the greatest levels of caregiver strain in Parkinson’s

    A. Hand, L. Oates, W. Gray, R. Walker (North Shields, United Kingdom)

    Objective: To identify factors that cause the greatest levels of caregiver strain in moderate to advanced Parkinson’s Disease (PD) Background: Many people with PD (PwP)…
  • 2017 International Congress

    Degree, onset and longevity of benefit achieved with Deep Brain Stimulation (DBS) of the subthalamic nucleus (STN) as assessed by the UPDRS.

    D. Caputo, O. Mark, D. Schneider, R. DiPaola, S. Danish, E. Hargreaves (New Brunswick, NJ, USA)

    Objective:  To show the degree, onset and longevity of benefit achieved with STN DBS at our center. Background: At our center, we administer the UPDRS-III…
  • 2017 International Congress

    GammaKnife subthalamotomy for Parkinson’s disease

    t. witjas, r. carron, a. eusebio, j.p. azulay, j. regis (marseille, France)

    Objective: To assess the feasibility of GammaKnife subthalamotomy in Parkinson's disease Background: Chronic STN stimulation is an established treatment for complicated PD. Bilateral subthalamotomy may…
  • 2017 International Congress

    The Accreditation and Certification of the Movement Disorders Subspecialty

    S. O'Shea, L. Gutmann, L. Faulkner (New York, NY, USA)

    Objective: The purpose of our study was to assess the sentiments of Movement Disorders fellowship program directors regarding the accreditation and certification of their subspecialty.…
  • 2017 International Congress

    Neuroprotective Potency of Tetrahydroisoquinoline a Novel Ayurveda Molecule in Experimental Parkinson’s Disease

    R. Banerjee, D. Nthenge-Ngumbau, R. Singh, P. Jaisankar, K. Mohanakumar, S. Biswas (Kolkata, India)

    Objective: Tetrahydroisoquinoline (TIQ) an identified alkaloid from ancient Indian ‘Ayurveda’ medicine for Parkinson’s disease (PD) was tested for neuroprotection in a cellular system and a…
  • « Previous Page
  • 1
  • …
  • 313
  • 314
  • 315
  • 316
  • 317
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley